CDSCO

Covaxin demonstrates robust safety and immunogenicity in two-to-18 year old: Study

Read more

Covovax better booster for Covishield-vaccinated people: Shahid Jameel

Read more

DCGI seeks more data from SII over its application seeking emergency authorisation for Covovax

Read more

Boehringer Ingelheim launches additional heart failure indication for Jardiance in India

Read more

Health Minister launches sixth edition of National Formulary of India (NFI)

Read more

Bharat Biotech awaits regulatory approvals to launch Covaxin for children

Read more

Bharat Biotech submits clinical trial data of Covaxin in children to CDSCO

Read more

J&J seeks Indian regulator’s nod for COVID vaccine trials on adolescents

Read more

CDSCO approves study on mixing of Covaxin and Covishield doses

Read more

Centre allows research on AYUSH Medicines to curb COVID-19

Read more